Pfizer Inc. PFE, -0.31% and BioNTech SE BNTX, + 2.80% He said Monday night that they have started a late-stage clinical trial for one of their COVID-19 vaccine candidates, which involves 30,000 people worldwide. The start of the trial “is a great step forward in our progress towards the provision …
Read More »AstraZeneca stocks drop 3% as results of early-stage study on coronavirus vaccine released
Shares of AstraZeneca AZN, -0.75% AZN + 3.16% They fell 3.4% in trade on Monday after a medical journal published a study that found the company’s COVID-19 vaccine candidate produced antibody and T-cell responses in participants in a phase 1/2 clinical trial. . AstraZeneca is developing the experimental vaccine with …
Read More »FDA issues rules for developers of coronavirus vaccines
The Food and Drug Administration (FDA) issued new rules Tuesday for companies developing COVID-19 vaccines. “While the FDA is committed to helping expedite this work, we are not going to cut corners in our decision making, and we are clarifying in our guidance what data we need, which needs to …
Read More »